Debrisoquin (hydroiodide) is the hydrochloride form of Debrisoquin (HY-B1624). Debrisoquin is a TMPRSS2inhibitors that inhibitsSARS-CoV-2 entry into human lung cell line by a TMPRSS2-depedent manner. Debrisoquin can be used forantiviralresearch[1].
References
[1] Amanda L. Peiffer, et.al.TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform.ACS Medicinal Chemistry Letters 2023 14 (6), 860-866.
